Africa: Game-Changing HIV Prevention Injectable Set To Reach Several African Countries

[MSF] In 2022, the WHO recommended the innovative long-acting injectable version of HIV Pre-exposure Prophylaxis (PrEP), Cabotegravir (CAB-LA), as part of a comprehensive approach to HIV prevention. CAB-LA has been described as a potential game-changer in the fight against HIV, a disease that has affected many people. Nearly 40 million people were living with HIV at the end of 2023, while over 88 million have been infected since the beginning of the epidemic.



Source link : https://allafrica.com/stories/202411220241.html

Author :

Publish date : 2024-11-22 10:00:07

Copyright for syndicated content belongs to the linked Source.